{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:48:59Z","timestamp":1740163739927,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/16\/77\/32400"],"award-info":[{"award-number":["PG\/16\/77\/32400"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council","award":["MR\/P015816\/1"],"award-info":[{"award-number":["MR\/P015816\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischaemic heart disease is the world\u2019s leading cause of mortality. Survival rates from acute myocardial infarction (MI) have improved in recent years; however, this has led to an increase in the prevalence of heart failure (HF) due to chronic remodelling of the infarcted myocardium, for which treatment options remain poor. We have previously shown that inhibition of isoform 4 of the plasma membrane calcium ATPase (PMCA4) prevents chronic remodelling and HF development during pressure overload, through fibroblast mediated Wnt signalling modulation. Given that Wnt signalling also plays a prominent role during remodelling of the infarcted heart, this study investigated the effect of genetic and functional loss of PMCA4 on cardiac outcomes following MI. Neither genetic deletion nor pharmacological inhibition of PMCA4 affected chronic remodelling of the post-MI myocardium. This was the case when PMCA4 was deleted globally, or specifically from cardiomyocytes or fibroblasts. PMCA4-ablated hearts were however less prone to acute arrhythmic events, which may offer a slight survival benefit. Overall, this study demonstrates that PMCA4 inhibition does not affect chronic outcomes following MI.<\/jats:p>","DOI":"10.1038\/s41598-021-81170-2","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:02:30Z","timestamp":1610708550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia"],"prefix":"10.1038","volume":"11","author":[{"given":"Nicholas","family":"Stafford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Baudoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M. A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhpal","family":"Prehar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"De Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Neyses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delvac","family":"Oceandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"81170_CR1","unstructured":"Wilkins, E. et al. European Cardiovascular Disease Statistics 2017. (2017)."},{"key":"81170_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/cir.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin, E. J. et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139, e56\u2013e528. https:\/\/doi.org\/10.1161\/cir.0000000000000659 (2019).","journal-title":"Circulation"},{"key":"81170_CR3","volume-title":"Cardiovascular Disease Statistics 2015","author":"N Townsend","year":"2015","unstructured":"Townsend, N., Bhatnagar, P., Wilkins, E. & Wickramasinghe, K. Cardiovascular Disease Statistics 2015 (British Heart Foundation, London, 2015)."},{"key":"81170_CR4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/s0140-6736(18)32203-7","volume":"392","author":"GA Roth","year":"2018","unstructured":"Roth, G. A. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736\u20131788. https:\/\/doi.org\/10.1016\/s0140-6736(18)32203-7 (2018).","journal-title":"Lancet"},{"key":"81170_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","volume":"102","author":"P Bhatnagar","year":"2016","unstructured":"Bhatnagar, P., Wickramasinghe, K., Wilkins, E. & Townsend, N. Trends in the epidemiology of cardiovascular disease in the UK. Heart 102, 1945\u20131952. https:\/\/doi.org\/10.1136\/heartjnl-2016-309573 (2016).","journal-title":"Heart"},{"key":"81170_CR6","doi-asserted-by":"publisher","first-page":"2579832","DOI":"10.1155\/2016\/2579832","volume":"2016","author":"A Galli","year":"2016","unstructured":"Galli, A. & Lombardi, F. Postinfarct left ventricular remodelling: a prevailing cause of heart failure. Cardiol. Res. Pract. 2016, 2579832. https:\/\/doi.org\/10.1155\/2016\/2579832 (2016).","journal-title":"Cardiol. Res. Pract."},{"key":"81170_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/circresaha.115.306567","volume":"118","author":"AT Owens","year":"2016","unstructured":"Owens, A. T., Brozena, S. C. & Jessup, M. New management strategies in heart failure. Circ. Res. 118, 480\u2013495. https:\/\/doi.org\/10.1161\/circresaha.115.306567 (2016).","journal-title":"Circ. Res."},{"key":"81170_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.116.304346","volume":"116","author":"M Gy\u00f6ngy\u00f6si","year":"2015","unstructured":"Gy\u00f6ngy\u00f6si, M. et al. Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ. Res. 116, 1346\u20131360. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304346 (2015).","journal-title":"Circ. Res."},{"key":"81170_CR9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/s0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg, B. et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet 387, 1178\u20131186. https:\/\/doi.org\/10.1016\/s0140-6736(16)00082-9 (2016).","journal-title":"Lancet"},{"key":"81170_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 37, 2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128 (2016).","journal-title":"Eur. Heart J."},{"key":"81170_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1152\/physrev.00028.2016","volume":"97","author":"N Stafford","year":"2017","unstructured":"Stafford, N., Wilson, C., Oceandy, D., Neyses, L. & Cartwright, E. J. The plasma membrane calcium ATPases and their role as major new players in human disease. Physiol. Rev. 97, 1089\u20131125. https:\/\/doi.org\/10.1152\/physrev.00028.2016 (2017).","journal-title":"Physiol. Rev."},{"key":"81170_CR12","doi-asserted-by":"publisher","first-page":"41520","DOI":"10.1074\/jbc.M111.290411","volume":"286","author":"TM Mohamed","year":"2011","unstructured":"Mohamed, T. M. et al. Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain. J. Biol. Chem. 286, 41520\u201341529. https:\/\/doi.org\/10.1074\/jbc.M111.290411 (2011).","journal-title":"J. Biol. Chem."},{"key":"81170_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1172\/jci36693","volume":"119","author":"X Wu","year":"2009","unstructured":"Wu, X. et al. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J. Clin. Invest. 119, 976\u2013985. https:\/\/doi.org\/10.1172\/jci36693 (2009).","journal-title":"J. Clin. Invest."},{"key":"81170_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cvr\/cvq077","volume":"87","author":"M Holton","year":"2010","unstructured":"Holton, M. et al. Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovasc. Res. 87, 440\u2013448. https:\/\/doi.org\/10.1093\/cvr\/cvq077 (2010).","journal-title":"Cardiovasc. Res."},{"key":"81170_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1083\/jcb.200104131","volume":"155","author":"K Schuh","year":"2001","unstructured":"Schuh, K., Uldrijan, S., Telkamp, M., Rothlein, N. & Neyses, L. The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J. Cell Biol. 155, 201\u2013205. https:\/\/doi.org\/10.1083\/jcb.200104131 (2001).","journal-title":"J. Cell Biol."},{"key":"81170_CR16","doi-asserted-by":"publisher","first-page":"29479","DOI":"10.1074\/jbc.M501326200","volume":"280","author":"MH Buch","year":"2005","unstructured":"Buch, M. H. et al. The sarcolemmal calcium pump inhibits the calcineurin\/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J. Biol. Chem. 280, 29479\u201329487. https:\/\/doi.org\/10.1074\/jbc.M501326200 (2005).","journal-title":"J. Biol. Chem."},{"key":"81170_CR17","doi-asserted-by":"publisher","first-page":"31318","DOI":"10.1074\/jbc.M307557200","volume":"279","author":"AL Armesilla","year":"2004","unstructured":"Armesilla, A. L. et al. Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J. Biol. Chem. 279, 31318\u201331328. https:\/\/doi.org\/10.1074\/jbc.M307557200 (2004).","journal-title":"J. Biol. Chem."},{"key":"81170_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/circulationaha.106.643791","volume":"115","author":"D Oceandy","year":"2007","unstructured":"Oceandy, D. et al. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation 115, 483\u2013492. https:\/\/doi.org\/10.1161\/circulationaha.106.643791 (2007).","journal-title":"Circulation"},{"key":"81170_CR19","doi-asserted-by":"publisher","first-page":"12091","DOI":"10.1074\/jbc.M809112200","volume":"284","author":"TM Mohamed","year":"2009","unstructured":"Mohamed, T. M. et al. Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J. Biol. Chem. 284, 12091\u201312098. https:\/\/doi.org\/10.1074\/jbc.M809112200 (2009).","journal-title":"J. Biol. Chem."},{"key":"81170_CR20","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1038\/ncomms11074","volume":"7","author":"TM Mohamed","year":"2016","unstructured":"Mohamed, T. M. et al. The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy. Nat. Commun. 7, 11074. https:\/\/doi.org\/10.1038\/ncomms11074 (2016).","journal-title":"Nat. Commun."},{"key":"81170_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.RES.0000092142.19896.D9","volume":"93","author":"R Gros","year":"2003","unstructured":"Gros, R. et al. Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circ. Res. 93, 614\u2013621. https:\/\/doi.org\/10.1161\/01.RES.0000092142.19896.D9 (2003).","journal-title":"Circ. Res."},{"key":"81170_CR22","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/atvbaha.114.304363","volume":"34","author":"RR Baggott","year":"2014","unstructured":"Baggott, R. R. et al. Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin. Arterioscler. Thromb. Vasc. Biol. 34, 2310\u20132320. https:\/\/doi.org\/10.1161\/atvbaha.114.304363 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"81170_CR23","doi-asserted-by":"publisher","first-page":"28220","DOI":"10.1074\/jbc.M312599200","volume":"279","author":"K Schuh","year":"2004","unstructured":"Schuh, K. et al. Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility. J. Biol. Chem. 279, 28220\u201328226. https:\/\/doi.org\/10.1074\/jbc.M312599200 (2004).","journal-title":"J. Biol. Chem."},{"key":"81170_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2013.07.007","volume":"63","author":"TM Mohamed","year":"2013","unstructured":"Mohamed, T. M. et al. Development and characterization of a novel fluorescent indicator protein PMCA4-GCaMP2 in cardiomyocytes. J. Mol. Cell Cardiol. 63, 57\u201368. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.07.007 (2013).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/jcmm.13371","volume":"22","author":"S Lewis","year":"2018","unstructured":"Lewis, S. et al. Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS-dependent mechanism. J. Cell Mol. Med. 22, 861\u2013872. https:\/\/doi.org\/10.1111\/jcmm.13371 (2018).","journal-title":"J. Cell Mol. Med."},{"key":"81170_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.07.001","volume":"109","author":"S Kurusamy","year":"2017","unstructured":"Kurusamy, S. et al. Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion. J. Mol. Cell Cardiol. 109, 38\u201347. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.07.001 (2017).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41401-018-0060-4","volume":"40","author":"WB Fu","year":"2019","unstructured":"Fu, W. B., Wang, W. E. & Zeng, C. Y. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol. Sin. 40, 9\u201312. https:\/\/doi.org\/10.1038\/s41401-018-0060-4 (2019).","journal-title":"Acta Pharmacol. Sin."},{"key":"81170_CR28","doi-asserted-by":"publisher","first-page":"21110","DOI":"10.1073\/pnas.1004708107","volume":"107","author":"W He","year":"2010","unstructured":"He, W. et al. Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc. Natl. Acad. Sci. USA 107, 21110\u201321115. https:\/\/doi.org\/10.1073\/pnas.1004708107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81170_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yjmcc.2015.12.024","volume":"91","author":"SD Francis Stuart","year":"2016","unstructured":"Francis Stuart, S. D., De Jesus, N. M., Lindsey, M. L. & Ripplinger, C. M. The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J. Mol. Cell Cardiol. 91, 114\u2013122. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.024 (2016).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR30","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/circulationaha.113.007497","volume":"129","author":"S Zaman","year":"2014","unstructured":"Zaman, S. & Kovoor, P. Sudden cardiac death early after myocardial infarction: pathogenesis, risk stratification, and primary prevention. Circulation 129, 2426\u20132435. https:\/\/doi.org\/10.1161\/circulationaha.113.007497 (2014).","journal-title":"Circulation"},{"key":"81170_CR31","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski, M., Chen, W. & Frangogiannis, N. G. Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J. Mol. Cell Cardiol. 51, 600\u2013606. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.10.033 (2011).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1042\/cs20171337","volume":"132","author":"AM Sadi","year":"2018","unstructured":"Sadi, A. M. et al. Cardiac-specific inducible overexpression of human plasma membrane Ca(2+) ATPase 4b is cardioprotective and improves survival in mice following ischemic injury. Clin. Sci. (Lond.) 132, 641\u2013654. https:\/\/doi.org\/10.1042\/cs20171337 (2018).","journal-title":"Clin. Sci. (Lond.)"},{"key":"81170_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/circresaha.110.221531","volume":"107","author":"S Gessert","year":"2010","unstructured":"Gessert, S. & Kuhl, M. The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ. Res. 107, 186\u2013199. https:\/\/doi.org\/10.1161\/circresaha.110.221531 (2010).","journal-title":"Circ. Res."},{"key":"81170_CR34","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/circresaha.110.223768","volume":"107","author":"MW Bergmann","year":"2010","unstructured":"Bergmann, M. W. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ. Res. 107, 1198\u20131208. https:\/\/doi.org\/10.1161\/circresaha.110.223768 (2010).","journal-title":"Circ. Res."},{"key":"81170_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00395-018-0705-y","volume":"113","author":"IS Meyer","year":"2018","unstructured":"Meyer, I. S. & Leuschner, F. The role of Wnt signaling in the healing myocardium: a focus on cell specificity. Basic Res. Cardiol. 113, 44. https:\/\/doi.org\/10.1007\/s00395-018-0705-y (2018).","journal-title":"Basic Res. Cardiol."},{"key":"81170_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1242\/dmm.006510","volume":"4","author":"O Aisagbonhi","year":"2011","unstructured":"Aisagbonhi, O. et al. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis. Model. Mech. 4, 469\u2013483. https:\/\/doi.org\/10.1242\/dmm.006510 (2011).","journal-title":"Dis. Model. Mech."},{"key":"81170_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00395-010-0100-9","volume":"105","author":"MI Oerlemans","year":"2010","unstructured":"Oerlemans, M. I. et al. Active Wnt signaling in response to cardiac injury. Basic Res. Cardiol. 105, 631\u2013641. https:\/\/doi.org\/10.1007\/s00395-010-0100-9 (2010).","journal-title":"Basic Res. Cardiol."},{"key":"81170_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/jaha.116.004387","volume":"6","author":"D Palevski","year":"2017","unstructured":"Palevski, D. et al. Loss of macrophage Wnt secretion improves remodeling and function after myocardial infarction in mice. J. Am. Heart Assoc. 6, 4. https:\/\/doi.org\/10.1161\/jaha.116.004387 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"81170_CR39","doi-asserted-by":"publisher","first-page":"18366","DOI":"10.1073\/pnas.0803437105","volume":"105","author":"MP Alfaro","year":"2008","unstructured":"Alfaro, M. P. et al. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc. Natl. Acad. Sci. USA 105, 18366\u201318371. https:\/\/doi.org\/10.1073\/pnas.0803437105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81170_CR40","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1073\/pnas.0610024104","volume":"104","author":"M Mirotsou","year":"2007","unstructured":"Mirotsou, M. et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. USA 104, 1643\u20131648. https:\/\/doi.org\/10.1073\/pnas.0610024104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81170_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncb1811","volume":"11","author":"K Kobayashi","year":"2009","unstructured":"Kobayashi, K. et al. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat. Cell Biol. 11, 46\u201355. https:\/\/doi.org\/10.1038\/ncb1811 (2009).","journal-title":"Nat. Cell Biol."},{"key":"81170_CR42","doi-asserted-by":"publisher","first-page":"C531","DOI":"10.1152\/ajpcell.00238.2013","volume":"306","author":"M Mastri","year":"2014","unstructured":"Mastri, M. et al. Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention. Am. J. Physiol. Cell Physiol. 306, C531-539. https:\/\/doi.org\/10.1152\/ajpcell.00238.2013 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"81170_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yjmcc.2010.03.018","volume":"49","author":"S Sciarretta","year":"2010","unstructured":"Sciarretta, S. & Sadoshima, J. New insights into the molecular phenotype of eccentric hypertrophy. J. Mol. Cell Cardiol. 49, 153\u2013156. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.03.018 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/circulationaha.110.943431","volume":"122","author":"K Toischer","year":"2010","unstructured":"Toischer, K. et al. Differential cardiac remodeling in preload versus afterload. Circulation 122, 993\u20131003. https:\/\/doi.org\/10.1161\/circulationaha.110.943431 (2010).","journal-title":"Circulation"},{"key":"81170_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/circresaha.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91\u2013112. https:\/\/doi.org\/10.1161\/circresaha.116.303577 (2016).","journal-title":"Circ. Res."},{"key":"81170_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan, X. et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell Cardiol. 62, 24\u201335. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.04.023 (2013).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","volume":"70","author":"AV Shinde","year":"2014","unstructured":"Shinde, A. V. & Frangogiannis, N. G. Fibroblasts in myocardial infarction: a role in inflammation and repair. J. Mol. Cell Cardiol. 70, 74\u201382. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.11.015 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"81170_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","volume":"131","author":"Y Xia","year":"2009","unstructured":"Xia, Y. et al. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem. Cell Biol. 131, 471\u2013481. https:\/\/doi.org\/10.1007\/s00418-008-0541-5 (2009).","journal-title":"Histochem. Cell Biol."},{"key":"81170_CR49","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/circulationaha.110.010264","volume":"124","author":"S Banquet","year":"2011","unstructured":"Banquet, S. et al. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 124, 1059\u20131069. https:\/\/doi.org\/10.1161\/circulationaha.110.010264 (2011).","journal-title":"Circulation"},{"key":"81170_CR50","doi-asserted-by":"publisher","first-page":"e002192","DOI":"10.1161\/JAHA.115.002192","volume":"4","author":"CY Lin","year":"2015","unstructured":"Lin, C. Y. et al. Prognostic significance of premature atrial complexes burden in prediction of long-term outcome. J. Am. Heart Assoc. 4, e002192. https:\/\/doi.org\/10.1161\/JAHA.115.002192 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"81170_CR51","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/emboj.2011.289","volume":"30","author":"A Quintana","year":"2011","unstructured":"Quintana, A. et al. Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. Embo J. 30, 3895\u20133912. https:\/\/doi.org\/10.1038\/emboj.2011.289 (2011).","journal-title":"Embo J."},{"key":"81170_CR52","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/emboj.2011.495","volume":"31","author":"MF Ritchie","year":"2012","unstructured":"Ritchie, M. F., Samakai, E. & Soboloff, J. STIM1 is required for attenuation of PMCA-mediated Ca2+ clearance during T-cell activation. Embo J. 31, 1123\u20131133. https:\/\/doi.org\/10.1038\/emboj.2011.495 (2012).","journal-title":"Embo J."},{"key":"81170_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp207","author":"SW van den Borne","year":"2009","unstructured":"van den Borne, S. W. et al. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvp207 (2009).","journal-title":"Cardiovasc. Res."},{"key":"81170_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2007.04.041","author":"A Lindsley","year":"2007","unstructured":"Lindsley, A. et al. Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev. Biol. https:\/\/doi.org\/10.1016\/j.ydbio.2007.04.041 (2007).","journal-title":"Dev. Biol."},{"key":"81170_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119509","author":"R Agah","year":"1997","unstructured":"Agah, R. et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI119509 (1997).","journal-title":"J. Clin. Invest."},{"key":"81170_CR56","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1111\/bph.15193","volume":"177","author":"NP du Sert","year":"2020","unstructured":"du Sert, N. P. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Br. J. Pharmacol. 177, 3617\u20133624. https:\/\/doi.org\/10.1111\/bph.15193 (2020).","journal-title":"Br. J. Pharmacol."},{"issue":"102","key":"81170_CR57","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1152\/japplphysiol.00033.2007","volume":"1985","author":"J Takagawa","year":"2007","unstructured":"Takagawa, J. et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J. Appl. Physiol. 1985(102), 2104\u20132111. https:\/\/doi.org\/10.1152\/japplphysiol.00033.2007 (2007).","journal-title":"J. Appl. Physiol."},{"key":"81170_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81170-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81170-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81170-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:01:53Z","timestamp":1670032913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81170-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["81170"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-81170-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1518"}}